Medtronic Plc current report, 28 March 2017

Medtronic Plc Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Medtronic Public Limited Company on March 28, 2017. The filing reports the entry into a material definitive agreement regarding a new debt issuance by Medtronic, Inc., a subsidiary of the registrant.

Key Financial Metrics

  • Debt Issuance: $150,000,000 aggregate principal amount of 4.625% Senior Notes due 2045.
  • Interest Rate: 4.625% per annum.
  • Maturity Date: March 15, 2045.
  • Interest Payment Schedule: Semi-annually in arrears on March 15 and September 15, commencing September 15, 2017.
  • Guarantors: The Notes are fully and unconditionally guaranteed by Medtronic Public Limited Company and Medtronic Global Holdings S.C.A.
  • Ranking: General unsecured senior obligations ranking equally with other existing and future unsecured senior indebtedness.

Material Changes

This issuance represents a further issuance of Medtronic, Inc.'s 4.625% Senior Notes due 2045, adding to the $4,000,000,000 aggregate principal amount of "Existing Notes" issued on December 10, 2014. The filing does not provide comparative financial performance data (revenue, profit, cash flow) as it is a transaction-specific report rather than a periodic financial statement.

Guidance, Outlook, and Risks

  • Redemption Rights: Medtronic, Inc. has the right to redeem the Notes prior to maturity at its option by paying a "make-whole" premium plus accrued interest.
  • Events of Default: Includes payment defaults, covenant defaults, and bankruptcy/insolvency events, which may trigger acceleration of the entire principal amount.
  • Related Party Transactions: The filing discloses ongoing banking and advisory relationships with Wells Fargo Bank, National Association (Trustee) and the underwriters (Citigroup, Goldman Sachs, Morgan Stanley), noting they may receive customary fees for services.

Investor Verification Checklist

  • Verify the total outstanding principal of the 4.625% Senior Notes due 2045 following this $150 million issuance.
  • Review the "make-whole" premium calculation methodology in the Indenture for potential early redemption costs.
  • Confirm the credit rating implications of this additional unsecured senior debt.
  • Examine the specific covenants within the Base Indenture and Supplemental Indentures referenced in the filing.